Evidence map›Paper›PMID 39238661›Full record

ReviewInterventional pain medicine2023

Treatment of chest wall pain syndrome from oncologic etiology with neuromodulation: A narrative review.

Newaj M Abdullah, Robert H Jenkinson, Timothy R Deer, Jonathan M Hagedorn

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Interventional pain medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Newaj M AbdullahDivision of Pain Medicine, Department of Anesthesiology, University of Utah, Salt Lake City, UT, USA.
Robert H JenkinsonDivision of Pain Medicine, Department of Anesthesiology, University of Utah, Salt Lake City, UT, USA.
Timothy R DeerThe Spine and Nerve Center of the Virginias, Charleston, WV, USA.
Jonathan M HagedornDepartment of Anesthesiology and Perioperative Medicine, Division of Pain Medicine, Mayo Clinic, Rochester, MN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pain affects 50% of patients with cancer. Cancer-related pain occurs from tumor invasion as well as a sequela from cancer treatment. Despite numerous and often significant side effects, opioid, and neuropathic pain medications remain the mainstays of treatment for cancer-related pain. Neuromodulation-based treatment approaches including SCS, DRGS, and PNS are becoming increasingly common in the cancer pain landscape. In this narrative review, we present 11 case reports and case series that highlight the usefulness of neuromodulation for the treatment of chest wall pain from various cancer-related pathologies. Of the 34 patients included in these reports, 30 patients (88.25%) derived meaningful pain relief with the use of neuromodulation-based approaches. In addition, a majority of patients were able to reduce or eliminate their opioid requirements. This review provides early evidence that neuromodulation can be an effective treatment option for the treatment of cancer-related chest wall pain and set the backdrop for future clinical trials.

Indexed as

Chest wall painDorsal root ganglion stimulationNeuromodulationPeripheral nerve stimulationPost-mastectomy pain syndromePost-thoracotomy pain syndrome

Identifiers

PMID39238661
PMCPMC11372950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.